Contrary to observations in lung cancer 65, where YTHDC2 was reported to diminish SLC7A11 expression through reduced SLC7A11 mRNA stability, our findings reveal that YTHDC2 facilitates the upregulation of SLC7A11 expression by enhancing its translational efficiency in the epileptic condition. This evidence concerns the gene SLC7A11 and lung cancer.